SRT1720 , ≥98% , 1001645-58-4
Synonym(s):
InSolution SRT1720, HCl - CAS 1001645-58-4 - Calbiochem
CAS NO.:1001645-58-4
Empirical Formula: C25H24ClN7OS
Molecular Weight: 506.022
MDL number: MFCD18074509
Pack Size | Price | Stock | Quantity |
5MG | RMB628.80 | In Stock |
|
10MG | RMB1152.80 | In Stock |
|
250mg | RMB4319.20 | In Stock |
|
50MG | RMB4542.40 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | >205°C (dec.) |
Density | 1.58 |
storage temp. | = -70C |
solubility | Soluble in DMSO (>25 mg/ml) |
form | Liquid |
color | White |
Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
Description and Uses
SRT1720 (1001645-58-4) is a SIRT1 activator (EC1.5 = 0.16 μM, max activation = 781%).1 It reduced glucose levels and hyperinsulinemia in DIO, Lepob/ob mice and Zucker fa/fa rats.? SRT1720 enhanced endurance running and protected against diet-induced obesity and insulin resistance via enhancement of oxidative metabolism in skeletal muscle, liver, and brown adipose tissue.2 It induced mitochondrial biogenesis in oxidant-induced renal proximal tube cell injury.3 SRT1720 repressed circadian clock gene expression and decreased H3 K9/K14 acetylation in a time-specific manner.4 It attenuated angiotensin II-induced atherosclerosis by inhibiting the vascular inflammatory response.5
SRT1720 acts as a therapeutic in the treatment of type 2 diabetes. It modulates calories and contributes to glucose homeostasis and insulin sensitivity.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H302-H315-H319-H335 |
Precautionary statements | P261-P280-P301+P312-P302+P352-P305+P351+P338 |